PI
LGND icon

PineBridge Investments’s Ligand Pharmaceuticals LGND Stock Holding History

PineBridge Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-208
Closed -$15K – 859
2023
Q2 		$15K Buy
+208
New +$15.6K ﹤0.01% 842
2018
Q4 		– Sell
-6,979
Closed -$1.2M – 1103
2018
Q3 		$1.2M Buy
6,979
+1,433
+26% +$216K 0.02% 547
2018
Q2 		$717K Sell
5,546
-276
-5% -$30.8K 0.02% 642
2018
Q1 		$600K Sell
5,822
-6,451
-53% -$638K 0.01% 664
2017
Q4 		$1.05M Buy
12,273
+8,112
+195% +$703K 0.03% 558
2017
Q3 		$353K Buy
4,161
+141
+4% +$11.2K 0.01% 746
2017
Q2 		$304K Buy
4,020
+51
+1% +$3.57K 0.01% 723
2017
Q1 		$262K Buy
3,969
+14
+0.4% +$921 0.01% 750
2016
Q4 		$251K Buy
3,955
+87
+2% +$5.49K 0.01% 796
2016
Q3 		$246K Buy
3,868
+16
+0.4% +$1.18K 0.01% 441
2016
Q2 		$286K Buy
3,852
+301
+8% +$22.3K 0.01% 380
2016
Q1 		$237K Sell
3,551
-351
-9% -$21.3K 0.01% 428
2015
Q4 		$264K Buy
3,902
+255
+7% +$15.7K 0.01% 427
2015
Q3 		$194K Buy
3,647
+342
+10% +$20.8K 0.01% 525
2015
Q2 		$208K Sell
3,305
-4,091
-55% -$223K 0.01% 483
2015
Q1 		$356K Buy
7,396
+820
+12% +$31.4K 0.01% 546
2014
Q4 		$218K Buy
6,576
+29
+0.4% +$943 0.01% 689
2014
Q3 		$192K Buy
6,547
+1,352
+26% +$44.9K 0.01% 663
2014
Q2 		$202K Sell
5,195
-3,000
-37% -$122K 0.01% 547
2014
Q1 		$344K Sell
8,195
-782
-9% -$32.6K 0.01% 558
2013
Q4 		$295K Buy
+8,977
New +$292K 0.01% 652

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PineBridge Investments's LGND Position: Q3 2023 in Review

PineBridge Investments sold out of Ligand Pharmaceuticals (LGND) in Q3 2023, closing a stake of 208 shares — an estimated $15K sold.

PineBridge Investments first reported a position in LGND in Q4 2013 and held it in 21 quarters. The position peaked at $1.2M in Q3 2018. 196 funds tracked by Wall St. Rank hold LGND as of Q3 2023.

  • PineBridge Investments reported no remaining Ligand Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 208 Ligand Pharmaceuticals shares in Q3 2023, an estimated $15K.
  • PineBridge Investments first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 21 quarters.
  • PineBridge Investments's Ligand Pharmaceuticals position peaked at $1.2M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.